Liabilities of Virax Biolabs Group Ltd from 31 Mar 2021 to 31 Mar 2025

Taxonomy & unit
ifrs-full: USD
Summary
Virax Biolabs Group Ltd quarterly Liabilities in USD history and change rate from 31 Mar 2021 to 31 Mar 2025.
  • Virax Biolabs Group Ltd Liabilities for the quarter ending 31 Mar 2025 was $964,750, a 179% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Change (%)

Virax Biolabs Group Ltd Quarterly Liabilities (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $964,750 +$619,556 +179% 31 Mar 2025 20-F 02 Jul 2025 2025 FY
Q1 2024 $345,194 -$563,207 -62% 31 Mar 2024 20-F 02 Jul 2025 2025 FY
Q1 2023 $908,401 -$337,013 -27% 31 Mar 2023 20-F 20 Aug 2024 2024 FY
Q1 2022 $1,245,414 +$373,979 +43% 31 Mar 2022 20-F 14 Jun 2023 2023 FY
Q1 2021 $871,435 31 Mar 2021 20-F 12 Aug 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.